Dare Bioscience, Inc. Impairment of Long-Lived Assets to be Disposed of
Dare Bioscience, Inc. (DARE) reported Impairment of Long-Lived Assets to be Disposed of of $102.00 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf · last filed 2017-05-12
- Dare Bioscience, Inc. impairment of long-lived assets to be disposed of for the quarter ending 2017-03-31 was $102.00K.
| Period end | Impairment of Long-Lived Assets to be Disposed of 3 month |
|---|---|
| 2017-03-31 | $102.00K 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |